Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30462201 | 1.00 | CD44 (0.44) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL203946 | 0.86 | CYP3A4 (0.58) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| Hydrochloric Acid SCHEMBL4006326 | 0.83 | CYP3A4 (0.55) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL657760 | 0.80 | ALDH1A1 (0.65) | CYP3A4ALDH1A1TSHRTP53AHR | |
| SCHEMBL525350 | 0.79 | CYP3A4 (0.65) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL31213263 | 0.79 | CYP3A4 (0.52) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL1196837 | 0.79 | CYP3A4 (0.52) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL698002 | 0.79 | KDM4E (0.45) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| SCHEMBL1392591 | 0.79 | CYP3A4 (0.65) | CD44CYP3A4ALDH1A1TSHRTP53 | |
| Hydrochloric Acid SCHEMBL11784583 | 0.77 | ALDH1A1 (0.61) | CYP3A4ALDH1A1TSHRTP53AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707773-A | Preparation method and application of maleimide structure-containing compound | 中国农业大学 | 2025-03-28 | — | — | CN | claimed |
| CN-113461562-A | Synthetic method of chlorantraniliprole pesticide intermediate 2-amino-5-chloro-N, 3-dimethyl benzamide | 刘辉 | 2021-10-01 | — | — | CN | claimed |
| US-7795441-B2 | Process for preparing imino compounds | BASELL POLYOLEFINE GMBH (DE) | 2010-09-14 | — | — | US | claimed |
| EP-1066269-B1 | TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2005-05-11 | — | — | EP | claimed |
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | DAEYAERT FREDERIK FRANS DESIRE (BE) | 2002-08-22 | — | — | US | claimed |
| US-6150360-A | ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-11-21 | — | — | US | claimed |
| US-4096333-A | NITROSATION OF A 2-METHYLACETANILIDE | TENNECO CHEMICALS, INC. (US) | 1978-06-20 | — | — | US | claimed |
| EP-3927685-B1 | A PROCESS FOR THE SYNTHESIS ANTHRANILIC DIAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD (IN) | 2025-10-08 | — | — | EP | disclosed |
| CN-119707773-A | Preparation method and application of maleimide structure-containing compound | 中国农业大学 | 2025-03-28 | — | — | CN | disclosed |
| US-11718584-B2 | Process for the synthesis anthranilic diamide compounds and intermediates thereof | PI INDUSTRIES LTD. (IN) | 2023-08-08 | — | — | US | disclosed |
| CN-115583895-B | Synthetic method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 苏州开元民生科技股份有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-115583895-A | Synthetic method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 苏州开元民生科技股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-110845341-B | Preparation method of 2-amino-5-chloro-N, 3-dimethylbenzamide | 苏州开元民生科技股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| US-4203920-A | ANTIDIARRHEAL | WILLIAM H. RORER, INC. (US) | 1980-05-20 | — | — | US | disclosed |
| US-4147804-A | ANTIARRHYTHMIA AGENTS | WILLIAM H. RORER, INC. (US) | 1979-04-03 | — | — | US | disclosed |
| US-4141718-A | ANTIGROWTH AGENTS FOR PLANTS | CIBA-GEIGY CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-4060635-A | Amidinoureas for treating diarrhea | WILLIAM H. RORER, INC. (US) | 1977-11-29 | — | — | US | disclosed |
| US-4034043-A | PRODUCTION OF 2-AMINO-5-CHLORO-TOLUENE HYDROCHLORIDE | CIBA-GEIGY CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
| US-3933851-A | Preparation of aromatic 2-imino-1,3-dithietanes | AMERICAN CYANAMID COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3931340-A | Chlorination of aromatic compounds | ASAHI DENKA KOGYO K.K. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115668-A1 | Trisubstituted 1,3,5-triazine derivatives | XDH, CCR5, CXCR1 | CD44 4839/4885CYP3A4 174/4885ALDH1A1 3722/4885 |
| US-11718584-B2 | Process for the synthesis anthranilic diamide compounds and intermediates thereof | DAO, DDC, QDPR | CD44 4854/4885CYP3A4 44/4885ALDH1A1 914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.